导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 37.80% | 91/1050 |
| 近一周 | -1.97% | 392/1104 |
| 近一月 | -8.43% | 945/1102 |
| 近一季 | -8.53% | 603/1092 |
| 近半年 | 28.44% | 82/1070 |
| 近一年 | 60.59% | 41/1018 |
| 近两年 | 281.90% | 16/926 |
| 近三年 | 205.66% | 19/834 |
| 成立以来 | 156.30% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
5.73% 117/1070 |
77.20% 122/1101 |
- - |
- - |
| 2025 | 96.46% 13/1065 |
-2.06% 913/1014 |
7.30% 183/1038 |
73.94% 7/1050 |
7.47% 80/1065 |
| 2024 | 13.64% 207/1011 |
-11.50% 813/960 |
0.42% 276/983 |
15.04% 226/991 |
11.15% 59/1011 |
| 2023 | -30.79% 816/952 |
0.13% 624/880 |
-5.62% 564/895 |
-24.64% 883/915 |
-2.82% 308/952 |
| 2022 | -25.99% 528/867 |
-22.12% 642/773 |
12.48% 177/806 |
-8.85% 190/845 |
-7.31% 715/867 |
| 2021 | 12.19% 216/740 |
-12.19% 528/580 |
24.10% 100/659 |
3.55% 154/704 |
-0.57% 463/740 |
| 2020 | 47.19% 253/554 |
10.04% 43/419 |
27.73% 149/466 |
-3.21% 449/517 |
8.19% 387/554 |
| 2019 | 32.32% 276/410 |
25.42% 677/1149 |
-1.42% 478/1231 |
1.86% 281/390 |
5.07% 339/410 |
| 2018 | -18.91% 57/349 |
- - |
- - |
- - |
-10.65% 348/1080 |
| 2017 | 19.33% 85/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 长信创新驱动股票 VS. 东吴新产业精选股票A(580008) |